AdvaMed’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
Scott Whitaker, President and CEO, of AdvaMed recently had the opportunity to speak with Ambassador Kurt Volker, a distinguished diplomat who served as U.S. Ambassador to NATO and U.S. Special…
Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
Ethylene oxide sterilization ensures billions of pieces of medical technology are sterile for patients in every medical setting, in surgical procedures from c-sections to knee replacements.
According to a senior toxicologist in a RealClearPolicy op-ed, the EPA draws unreasonable conclusions about the health risks of the ethylene oxide used to sterilize medical technology.
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed convened sustainability leaders at its annual MedTech Conference last fall for a panel discussion that featured panelists across the entire medtech value chain.
This Women’s Health Month, AdvaMed is highlighting new developments in breast cancer screening.
AdvaMed and its member companies are working with the U.S. government on medtech donations for humanitarian aid following the devastating earthquakes in southeast Turkey and northern Syria.
This April, AdvaMed celebrated the 30th anniversary of its Code of Ethics on Interactions with Health Care Professionals .
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-316-1423
It is easy to take for granted the role medtech plays in our everyday lives. From heart valves, imaging equipment, and pacemakers to continuous glucose monitors, we rely on these technologies to…
Join over 400 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.